Page last updated: 2024-09-05

erlotinib hydrochloride and Depression

erlotinib hydrochloride has been researched along with Depression in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dongying, L; Ling, L; Yanwei, L; Yu, Z; Zhanyu, P; Zhuchen, Y	1
Greer, J; Lynch, TJ; Pirl, WF; Sequist, L; Solis, J; Temel, JS	1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Depression

Article	Year
A double-edged sword: Should stage IV non-small cell lung cancer patients be informed of their cancer diagnosis? European journal of cancer care, 2017, Volume: 26, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Anxiety; Awareness; Carcinoma, Non-Small-Cell Lung; Depression; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Neoplasm Staging; Prognosis; Quality of Life; Stress, Psychological; Truth Disclosure; Young Adult	2017
Epidermal growth factor receptor tyrosine kinase inhibitors and depression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Aug-10, Volume: 27, Issue:23 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Depression; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines	2009

Article

Year

A double-edged sword: Should stage IV non-small cell lung cancer patients be informed of their cancer diagnosis?

European journal of cancer care, 2017, Volume: 26, Issue:6

Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Anxiety; Awareness; Carcinoma, Non-Small-Cell Lung; Depression; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Neoplasm Staging; Prognosis; Quality of Life; Stress, Psychological; Truth Disclosure; Young Adult

2017

Epidermal growth factor receptor tyrosine kinase inhibitors and depression.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Aug-10, Volume: 27, Issue:23

Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Depression; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines

2009